TL;DR
This paper introduces a novel deep learning (DL) approach to automatically identify epileptogenic high-frequency oscillations (eHFOs) in EEG data, overcoming the limitations of manual analysis. By using a weakly supervised method trained on clinical outcomes, the DL model not only accurately classifies HFOs but also uncovers key features of eHFOs, demonstrating its potential to improve epilepsy surgery planning.
What Problem Does This Paper Address?
Epileptogenic high-frequency oscillations (HFOs) are promising biomarkers for pinpointing the seizure-generating regions in the brain (the epileptogenic zone or EZ). However, manually identifying and classifying these HFOs is a time-consuming process with significant variability between experts (poor inter-rater reliability). Crucially, there's no reliable method to distinguish HFOs originating from the EZ (epileptogenic HFOs or eHFOs) from those originating from healthy brain regions (non-epileptogenic HFOs or non-eHFOs). This distinction is vital for successful epilepsy surgery, as leaving eHFOs behind can lead to continued seizures.
Methods
The researchers developed a two-step deep learning framework. First, a supervised DL model was trained to mimic human experts in classifying HFOs into three categories: HFOs with spikes, HFOs without spikes, and artifacts. This step achieved high accuracy in replicating expert annotations.
The second, more innovative step, focused on discovering eHFOs using a weakly supervised approach. Instead of relying on expert labels for eHFOs, the model was trained using clinical outcomes (seizure freedom after surgery) and the location of electrodes (resected vs. preserved brain regions). The assumption was that HFOs in resected regions of seizure-free patients are likely epileptogenic, while those in preserved regions are not. This "weak labeling" was then refined by the DL model's "purification power" to automatically relabel HFOs and identify eHFOs.
To understand how the model made its decisions, a "reverse engineering" approach was employed. This involved perturbing the input data (e.g., altering time-frequency plots or amplitude-coding) and observing the impact on the model's output probability. This helped identify the salient features the DL model learned to associate with eHFOs.
Datasets
The study utilized intracranial EEG (iEEG) data from 19 children with medication-resistant epilepsy who underwent surgery.
- Training Data:
- 12,958 annotated HFO events from 19 patients for artifact detection and HFO with/without spike classification.
- 84,602 HFO events from 9 seizure-free patients for training the weakly supervised eHFO discovery model.
- Inference/Validation Data:
- 90-minute EEG segments from 15 patients who underwent resection were used for applying the trained DL models and mapping eHFOs.
- 14 patients with known 24-month post-operative seizure outcomes were used for predicting surgical success based on HFO resection ratios.
No new benchmarks were introduced; the study focused on applying DL to existing iEEG data and clinical outcomes.
Key Insights and Ideas
- DL as an Expert Mimic: Deep learning can effectively replicate the nuanced classifications of human experts in identifying HFOs and artifacts, potentially reducing the burden on clinicians.
- Weak Supervision for Discovery: Leveraging clinical outcomes (like seizure freedom) and anatomical information (resected vs. preserved tissue) as "weak labels" is a powerful way to discover novel biomarkers like eHFOs, bypassing the need for perfect expert annotations.
- Reverse Engineering for Interpretability: By systematically perturbing model inputs, researchers can gain insights into the features that drive DL model predictions, making these "black box" models more understandable and trustworthy for clinical applications.
- eHFOs as Predictive Biomarkers: The resection ratio of eHFOs (the proportion of detected eHFOs found in resected tissue) is a strong predictor of post-operative seizure freedom, outperforming general HFO detection.
- Salient eHFO Features: The DL model learned to associate eHFOs with specific time-frequency patterns (an "inverted T-shaped" signature) and the presence of spike-like activity, aligning with existing expert knowledge.
Key Results
- Expert Emulation: The DL model achieved high accuracy: 96.3% on artifact detection (F1 score 96.8%) and 86.5% on classifying HFOs with spikes (F1 score 80.8%) in a patient-wise cross-validation.
- eHFO Discovery: The weakly supervised model identified eHFOs that were clinically relevant. A significant majority (71.1%) of DL-discovered eHFOs were indeed HFOs with spikes, as identified by experts.
- Predictive Power of eHFOs: The resection ratio of eHFOs showed a significant positive correlation with post-operative seizure freedom (AUC = 0.87, p = 0.01), outperforming the resection ratio of all detected HFOs (AUC = 0.76, p = 0.06).
- Spatial Localization: eHFOs were found to cluster around the seizure onset zone (SOZ), while non-eHFOs were more diffusely distributed.
- Feature Identification: Perturbation analysis revealed that introducing signals in the "inverted T-shaped" frequency band and spike-like patterns in the time domain significantly increased the model's confidence in classifying an HFO as epileptogenic.
Limitations and Future Work
- Dataset Size: The study included a relatively small cohort of 19 patients, with only 14 having known post-operative outcomes. The authors suggest that including more patients and data from diverse institutions is crucial for further refining the DL algorithm and improving its generalizability.
- Pediatric Focus: All data were from pediatric patients, and the authors acknowledge that HFO morphology might vary with age and epilepsy pathology, potentially requiring different training strategies for adult populations.
- Channel Resection Status Subjectivity: While the study used resected vs. preserved channel status as a weak label, this determination was made by human experts reviewing images, which could introduce some subjectivity. Future work could explore more automated and objective methods for determining channel resection status.
- Future Directions: The authors plan to build models using data from over 100 patients and explore the discovery of new salient characteristics of eHFOs as DL models become more robust. They also aim to refine the method to distinguish epileptogenic HFOs more precisely, ultimately aiming to guide resection margins in clinical trials to improve post-operative seizure outcomes.
Summary updated